Oral deferiprone for iron chelation in people with thalassaemia

Overview of attention for article published in Cochrane database of systematic reviews, August 2013

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (90th percentile)
Above-average Attention Score compared to outputs of the same age and source (55th percentile)

So far, Altmetric has seen 1 blog post.

In June 2021, the US Food and Drug Administration (FDA) approved aducanumab, a monoclonal antibody, for the treatment of…